7 November 2001 in Movement Disorders
20 June 2014 in BMC Neurology
Pathogenic autoantibodies targeting the recently identified leucine rich glioma inactivated 1 protein and the subunit 1 of the N-methyl-D-aspartate receptor induce autoimmune encephalitis. A comparison of brain metabolic patterns in 18F-fluoro-2-deoxy-d-glucose positron emission tomography of anti-leucine rich glioma inactivated 1 protein and anti-N-methyl-D-aspartate receptor encephalitis patients has not been performed yet and shall be helpful in differentiating these two most common forms of autoimmune encephalitis.
1 January 2003 in Nuklearmedizin-Nuclear Medicine
Aims: Definition of the regional pattern of dopamine transporter (DAT) dysfunction in advanced Parkinson’s disease (PD) and evaluation of a potential correlation between DAT binding and symptoms; elucidation of the role of DAT imaging in the differential diagnosis of PD and multiple system atrophy (MSA); assessment and comparison of serotonin transporter (SERT) binding in PD and MSA. Methods: [123I]ß-CIT SPECT was performed in 14 patients with advanced PD, 10 with moderate MSA and 20 healthy persons. Specific to nonspecific tracer binding ratios (V3’’) were calculated via ROI analysis of uptake images at 4 h (SERT binding) and 24 h (DAT binding) p. i. Results: In PD bilateral reduction of striatal DAT binding (63-70%) was seen. The caudate ipsilateral to the clinically predominantly affected side showed relatively the least impairment. Significant correlations (r = -0.54 to -0.64) between DAT binding and Hoehn and Yahr stage, UPDRS-scores and duration of disease were found. In MSA DAT binding was less reduced (40-48%) targeting the putamen contralateral to the side of clinical predominance. Significantly lower SERT binding was observed in PD midbrain and MSA hypothalamus compared to controls – and in MSA relative to PD mesial frontal cortex. Conclusions: In advanced PD striatal DAT binding is markedly reduced with the least reduction in caudate ipsilateral to the clinically predominantly affected side. In moderate MSA with asymmetrical symptoms DAT dysfunction is predominant in the contralateral putamen, a pattern seen in early PD. The reduction of SERT in the midbrain area of PD patients suggests additional tegmental degeneration while in MSA the serotonergic system seems to be more generally affected. Ziele: Bestimmung der regionalen Verteilung der Dopamintransporter(DAT)-Dysfunktion bei fortgeschrittenem Morbus Parkinson (MP) und Korrelation der DAT-Bindung zur Symptomatik; Klärung der Bedeutung der DAT-Darstel-lung für die Differenzialdiagnose von MP und Multisystematrophie (MSA); Einschätzung und Vergleich der Serotonintransporter(SERT)-Bindung bei MP und MSA. Methoden: [123I]ß-CIT-SPECT wurde bei 14 Patienten mit fort-geschrittenem MP, 10 mit mittelgradiger MSA und 20 Gesunden durchgeführt. Quotienten von spezifischer zu unspezifischer Bindung des Tracers (V3‘‘) wurden durch ROI-Analysen der Tomogramme nach 4 h (SERT-Bindung) und 24 h (DAT Bindung) p. i. bestimmt. Ergebnisse: Bei MP fanden sich beidseits signifikante Reduktionen (63-70%) der striatalen DAT-Bindung. Im Nucleus caudatus ipsilateral zur klinisch hauptsächlich betroffenen Seite zeigte sich die geringste Minderung. Signifikante Korrelationen (r = -0,54 bis -0,64) zwischen DAT-Bindung und Hoehn-Yahr-Stadium, UPDRS-Score und Erkrankungsdauer wurden beobachtet. Bei MSA war die DAT-Bindung geringer reduziert (um 40-48%) – am deutlichsten im kontralateralen Putamen. Signifikant vermindert war die SERTBindung im Mittelhirn von MP- und Hypothalamus von MSA-Patienten gegenüber Gesunden, sowie im mesialen frontalen Kortex bei MSA im Vergleich zum MP. Schlussfolgerungen: Bei fortgeschrittenem MP ist die DAT Bin-dung im ipsilateral zur klinisch hauptsächlich betroffenen Seite gelegenen Caudatus relativ erhalten und im übrigen Striatum deutlich reduziert. Bei mittelgradiger MSA mit asymmetrischer Symptomatik findet sich wie beim frühen MP die deutlichste DAT-Dysfunktion im kontralateralen Putamen. Die Reduktion der SERT-Bindung im Mittelhirn bei MP lässt auf zusätzliche tegmentale Degeneration schließen, während bei MSA eher das serotonerge System insgesamt betroffen zu sein scheint. * Diese Arbeit ist Prof. Dr. Dr. h.c. Heinz Hundeshagen zum 75. Geburtstag gewidmet.
1 January 2003 in European Journal of Nuclear Medicine and Molecular Imaging
5 July 2016 in Frontiers in Psychiatry
In this study alterations in brain perfusion have been investigated in patients with Tourette syndrome (TS) compared to control subjects. In addition, we investigated the effects of deep brain stimulation (DBS) in both globus pallidus internus (GPi) and centromedian-parafascicular / ventralis oralis internus nuclei of the thalamus (CM/Voi), and sham (SHAM) stimulation on cerebral blood flow. In a prospective controlled, randomized, double-blind setting 5 severely affected adult patients with TS with predominant motor or vocal tics (mean total tic score on the Yale Global Tic Severity Scale: 39) underwent serial brain perfusion single photon emission computed tomography (SPECT) with 99mTc-ECD. Results were compared with data from 6 age-matched control subjects. All patients were investigated at four different time points: once before DBS implantation (preOP) and three times postoperatively. Postoperative scans were performed in a randomized order each after 3 months of either GPi, CM/Voi, or SHAM stimulation. At each investigation, patients were injected at rest while awake, but scanned during anaesthesia. This procedure ensured that neither anaesthesia nor movement artefacts influenced our results. Control subjects were investigated only once at baseline (without DBS or anaesthesia). At baseline, cerebral blood flow was significantly reduced in patients with TS (preOP) compared to controls in the central region, frontal and parietal lobe, specifically in Brodmann areas 1, 4-9, 30, 31, and 40. Significantly increased perfusion was found in the cerebellum. When comparing SHAM stimulation to preOP condition, we found significantly decreased perfusion in basal ganglia and thalamus, but increased perfusion in different parts of the frontal cortex. Compared to SHAM condition both GPi and thalamic stimulation resulted in a significant decrease in cerebral blood flow in basal ganglia and cerebellum, while perfusion in the frontal cortex was significantly increased. Our results provide substantial evidence that in TS brain perfusion is altered in the frontal cortex and the cerebellum and that these changes can be reversed by both: GPi and CM/Voi DBS.